KRAS and neoplasm: Lewis Lung Carcinoma (LLC) represents a highly tumorigenic mesenchymal K-Ras mutant squamous lung cancer model, characterized by low tumor cell-specific PD-L1 expression with limited response to anti-PD-L1 therapy (5, 6).